199 related articles for article (PubMed ID: 18317451)
1. Protein kinase C epsilon confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53.
Shankar E; Sivaprasad U; Basu A
Oncogene; 2008 Jun; 27(28):3957-66. PubMed ID: 18317451
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance.
Sivaprasad U; Shankar E; Basu A
Cell Death Differ; 2007 Apr; 14(4):851-60. PubMed ID: 17186022
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cepsilon activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-alpha-induced cell death.
Lu D; Huang J; Basu A
J Biol Chem; 2006 Aug; 281(32):22799-807. PubMed ID: 16785234
[TBL] [Abstract][Full Text] [Related]
4. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.
Wang C; Qi R; Li N; Wang Z; An H; Zhang Q; Yu Y; Cao X
J Biol Chem; 2009 Jun; 284(24):16183-16190. PubMed ID: 19376776
[TBL] [Abstract][Full Text] [Related]
5. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
6. S6 kinase 2 promotes breast cancer cell survival via Akt.
Sridharan S; Basu A
Cancer Res; 2011 Apr; 71(7):2590-9. PubMed ID: 21427355
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway.
Pespeni MH; Hodnett M; Abayasiriwardana KS; Roux J; Howard M; Broaddus VC; Pittet JF
Cancer Res; 2007 Mar; 67(6):2865-71. PubMed ID: 17363610
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells.
Goncharenko-Khaider N; Lane D; Matte I; Rancourt C; Piché A
Oncogene; 2010 Oct; 29(40):5523-36. PubMed ID: 20661217
[TBL] [Abstract][Full Text] [Related]
9. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
Chen X; Thakkar H; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
Oncogene; 2001 Sep; 20(42):6073-83. PubMed ID: 11593415
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C-epsilon regulates the apoptosis and survival of glioma cells.
Okhrimenko H; Lu W; Xiang C; Hamburger N; Kazimirsky G; Brodie C
Cancer Res; 2005 Aug; 65(16):7301-9. PubMed ID: 16103081
[TBL] [Abstract][Full Text] [Related]
11. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression.
Lee J; Hwangbo C; Lee JJ; Seo J; Lee JH
Oncol Rep; 2010 Jan; 23(1):229-37. PubMed ID: 19956887
[TBL] [Abstract][Full Text] [Related]
12. Hdm2 is a ubiquitin ligase of Ku70-Akt promotes cell survival by inhibiting Hdm2-dependent Ku70 destabilization.
Gama V; Gomez JA; Mayo LD; Jackson MW; Danielpour D; Song K; Haas AL; Laughlin MJ; Matsuyama S
Cell Death Differ; 2009 May; 16(5):758-69. PubMed ID: 19247369
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.
Ravid D; Maor S; Werner H; Liscovitch M
Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498
[TBL] [Abstract][Full Text] [Related]
14. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
16. Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C.
Tillman DM; Izeradjene K; Szucs KS; Douglas L; Houghton JA
Cancer Res; 2003 Aug; 63(16):5118-25. PubMed ID: 12941843
[TBL] [Abstract][Full Text] [Related]
17. PKCepsilon induces Bcl-2 by activating CREB.
Shankar E; Krishnamurthy S; Paranandi R; Basu A
Int J Oncol; 2010 Apr; 36(4):883-8. PubMed ID: 20198332
[TBL] [Abstract][Full Text] [Related]
18. Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway.
Chen J; Zhu H; Zhang Y; Cui MH; Han LY; Jia ZH; Wang L; Teng H; Miao LN
Mol Med Rep; 2015 Aug; 12(2):2622-8. PubMed ID: 25954860
[TBL] [Abstract][Full Text] [Related]
19. Long isoform of ErbB3 binding protein, p48, mediates protein kinase B/Akt-dependent HDM2 stabilization and nuclear localization.
Kim CK; Lee SB; Nguyen TL; Lee KH; Um SH; Kim J; Ahn JY
Exp Cell Res; 2012 Jan; 318(2):136-43. PubMed ID: 21930127
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis.
Peuhu E; Rivero-Müller A; Stykki H; Torvaldson E; Holmbom T; Eklund P; Unkila M; Sjöholm R; Eriksson JE
Oncogene; 2010 Feb; 29(6):898-908. PubMed ID: 19935713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
